• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米酶学在病毒、细菌和真菌病原体的检测和鉴定中的应用。

Applications of Nanozymology in the Detection and Identification of Viral, Bacterial and Fungal Pathogens.

机构信息

School of Chemistry and Physics, College of Agriculture Engineering and Science, University of KwaZulu-Natal, Durban 4041, South Africa.

出版信息

Int J Mol Sci. 2022 Apr 22;23(9):4638. doi: 10.3390/ijms23094638.

DOI:10.3390/ijms23094638
PMID:35563029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9100627/
Abstract

Nanozymes are synthetic nanoparticulate materials that mimic the biological activities of enzymes by virtue of their surface chemistry. Enzymes catalyze biological reactions with a very high degree of specificity. Examples include the horseradish peroxidase, lactate, glucose, and cholesterol oxidases. For this reason, many industrial uses of enzymes outside their natural environments have been developed. Similar to enzymes, many industrial applications of nanozymes have been developed and used. Unlike the enzymes, however, nanozymes are cost-effectively prepared, purified, stored, and reproducibly and repeatedly used for long periods of time. The detection and identification of pathogens is among some of the reported applications of nanozymes. Three of the methodologic milestones in the evolution of pathogen detection and identification include the incubation and growth, immunoassays and the polymerase chain reaction (PCR) strategies. Although advances in the history of pathogen detection and identification have given rise to novel methods and devices, these are still short of the response speed, accuracy and cost required for point-of-care use. Debuting recently, nanozymology offers significant improvements in the six methodological indicators that are proposed as being key in this review, including simplicity, sensitivity, speed of response, cost, reliability, and durability of the immunoassays and PCR strategies. This review will focus on the applications of nanozymes in the detection and identification of pathogens in samples obtained from foods, natural, and clinical sources. It will highlight the impact of nanozymes in the enzyme-linked immunosorbent and PCR strategies by discussing the mechanistic improvements and the role of the design and architecture of the nanozyme nanoconjugates. Because of their contribution to world health burden, the three most important pathogens that will be considered include viruses, bacteria and fungi. Although not quite seen as pathogens, the review will also consider the detection of cancer cells and helminth parasites. The review leaves very little doubt that nanozymology has introduced remarkable advances in enzyme-linked immunosorbent assays and PCR strategies for detecting these five classes of pathogens. However, a gap still exists in the application of nanozymes to detect and identify fungal pathogens directly, although indirect strategies in which nanozymes are used have been reported. From a mechanistic point of view, the nanozyme technology transfer to laboratory research methods in PCR and enzyme-linked immunosorbent assay studies, and the point-of-care devices such as electronic biosensors and lateral flow detection strips, that is currently taking place, is most likely to give rise to no small revolution in each of the six methodological indicators for pathogen detection and identification. While the evidence of widespread research reports, clinical trials and point-of-care device patents support this view, the gaps that still exist point to a need for more basic research studies to be conducted on the applications of nanozymology in pathogen detection and identification. The multidisciplinary nature of the research on the application of nanozymes in the detection and identification of pathogens requires chemists and physicists for the design, fabrication, and characterization of nanozymes; microbiologists for the design, testing and analysis of the methodologies, and clinicians or clinical researchers for the evaluation of the methodologies and devices in the clinic. Many reports have also implicated required skills in mathematical modelling, and electronic engineering. While the review will conclude with a synopsis of the impact of nanozymology on the detection and identification of viruses, bacteria, fungi, cancer cells, and helminths, it will also point out opportunities that exist in basic research as well as opportunities for innovation aimed at novel laboratory methodologies and devices. In this regard there is no doubt that there are numerous unexplored research areas in the application of nanozymes for the detection of pathogens. For example, most research on the applications of nanozymes for the detection and identification of fungi is so far limited only to the detection of mycotoxins and other chemical compounds associated with fungal infection. Therefore, there is scope for exploration of the application of nanozymes in the direct detection of fungi in foods, especially in the agricultural production thereof. Many fungal species found in seeds severely compromise their use by inactivating the germination thereof. Fungi also produce mycotoxins that can severely compromise the health of humans if consumed.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/3aa91180c163/ijms-23-04638-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/cb428511cffe/ijms-23-04638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/f3b431615665/ijms-23-04638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/354be4715032/ijms-23-04638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/8fec4c536ed8/ijms-23-04638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/05d8b16f9a8a/ijms-23-04638-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/b48eee71d211/ijms-23-04638-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/eacd5ec25dab/ijms-23-04638-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/61ff7bbc5b04/ijms-23-04638-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/c4ba5016f31e/ijms-23-04638-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/755ace56daef/ijms-23-04638-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/39415ee7a913/ijms-23-04638-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/72d000c8ccb6/ijms-23-04638-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/af615e289efe/ijms-23-04638-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/ff492c192832/ijms-23-04638-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/3aa91180c163/ijms-23-04638-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/cb428511cffe/ijms-23-04638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/f3b431615665/ijms-23-04638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/354be4715032/ijms-23-04638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/8fec4c536ed8/ijms-23-04638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/05d8b16f9a8a/ijms-23-04638-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/b48eee71d211/ijms-23-04638-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/eacd5ec25dab/ijms-23-04638-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/61ff7bbc5b04/ijms-23-04638-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/c4ba5016f31e/ijms-23-04638-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/755ace56daef/ijms-23-04638-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/39415ee7a913/ijms-23-04638-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/72d000c8ccb6/ijms-23-04638-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/af615e289efe/ijms-23-04638-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/ff492c192832/ijms-23-04638-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1d/9100627/3aa91180c163/ijms-23-04638-g015.jpg
摘要

纳米酶是通过表面化学模拟酶的生物活性的合成纳米颗粒材料。酶以非常高的特异性催化生物反应。例如辣根过氧化物酶、乳酸、葡萄糖和胆固醇氧化酶。出于这个原因,许多酶在其自然环境之外的工业用途已经得到了开发。类似的酶,许多纳米酶的工业应用已经得到了开发和使用。然而,与酶不同的是,纳米酶的制备、纯化、储存成本效益高,可以重复使用很长时间。病原体的检测和鉴定就是纳米酶的一些报道应用之一。病原体检测和鉴定方法学的三个里程碑包括孵育和生长、免疫测定和聚合酶链反应(PCR)策略。尽管病原体检测和鉴定的历史上的进展带来了新的方法和设备,但这些仍然缺乏即时护理使用所需的响应速度、准确性和成本。最近推出的纳米酶学在提出的六个方法学指标中显著提高了免疫测定和 PCR 策略的改进,包括简单性、敏感性、响应速度、成本、可靠性和耐用性。本综述将重点介绍纳米酶在从食品、自然和临床来源获得的样本中检测和鉴定病原体的应用。它将通过讨论纳米酶纳米缀合物的设计和结构的改进作用和酶联免疫吸附和 PCR 策略的作用,突出纳米酶在酶联免疫吸附和 PCR 策略中的应用。由于它们对世界卫生负担的贡献,将考虑三种最重要的病原体,包括病毒、细菌和真菌。尽管不能被视为病原体,但该综述还将考虑对癌细胞和寄生虫的检测。该综述几乎毫无疑问地表明,纳米酶学在检测这些五类病原体的酶联免疫吸附和 PCR 策略方面取得了显著进展。然而,在直接检测真菌病原体方面,纳米酶的应用仍然存在差距,尽管已经报道了间接策略。从机制的角度来看,纳米酶技术向聚合酶链反应和酶联免疫吸附试验研究的实验室研究方法以及电子生物传感器和横向流动检测条等即时护理设备的转移,目前正在发生,很可能在病原体检测和鉴定的六个方法学指标中引发不小的革命。虽然广泛的研究报告、临床试验和即时护理设备专利的证据支持这一观点,但仍然存在的差距表明,需要在纳米酶学在病原体检测和鉴定中的应用方面进行更多的基础研究。纳米酶在病原体检测和鉴定中的应用研究的多学科性质需要化学家、物理学家设计、制造和表征纳米酶;微生物学家设计、测试和分析方法,以及临床医生或临床研究人员在临床上评估方法和设备。许多报告还暗示需要数学建模和电子工程方面的技能。虽然该综述将以纳米酶学对病毒、细菌、真菌、癌细胞和寄生虫检测和鉴定的影响摘要结束,但它还将指出基础研究中的机会以及针对新的实验室方法和设备的创新机会。在这方面,毫无疑问,在纳米酶应用于病原体检测方面存在许多尚未探索的研究领域。例如,目前大多数关于纳米酶在真菌检测和鉴定中的应用研究仅限于检测真菌毒素和与真菌感染相关的其他化学化合物。因此,在食品中直接检测真菌,特别是在农业生产中,有探索纳米酶应用的空间。在种子中发现的许多真菌物种严重破坏了它们的发芽能力。真菌还产生真菌毒素,如果被人类食用,会严重损害人类健康。

相似文献

1
Applications of Nanozymology in the Detection and Identification of Viral, Bacterial and Fungal Pathogens.纳米酶学在病毒、细菌和真菌病原体的检测和鉴定中的应用。
Int J Mol Sci. 2022 Apr 22;23(9):4638. doi: 10.3390/ijms23094638.
2
Nanozymes: From New Concepts, Mechanisms, and Standards to Applications.纳米酶:从新概念、机制和标准到应用。
Acc Chem Res. 2019 Aug 20;52(8):2190-2200. doi: 10.1021/acs.accounts.9b00140. Epub 2019 Jul 5.
3
Recent Advances in Nanozyme-Mediated Strategies for Pathogen Detection and Control.纳米酶介导的病原体检测与控制策略的最新进展。
Int J Mol Sci. 2023 Aug 28;24(17):13342. doi: 10.3390/ijms241713342.
4
Enzyme mimic nanomaterials as nanozymes with catalytic attributes.酶模拟纳米材料作为具有催化属性的纳米酶。
Colloids Surf B Biointerfaces. 2023 Jan;221:112950. doi: 10.1016/j.colsurfb.2022.112950. Epub 2022 Oct 20.
5
Recent Advances in the Immunoassays Based on Nanozymes.纳米酶基免疫分析的最新进展
Biosensors (Basel). 2022 Dec 2;12(12):1119. doi: 10.3390/bios12121119.
6
The impact of hollow core-shell nanozymes in biosensing: A case study of p-FeO@PDA@ZIF-67.中空核壳纳米酶在生物传感中的应用:以 p-FeO@PDA@ZIF-67 为例。
Anal Chim Acta. 2024 Jun 22;1309:342701. doi: 10.1016/j.aca.2024.342701. Epub 2024 May 7.
7
Biosystem-Inspired Engineering of Nanozymes for Biomedical Applications.生物系统启发的纳米酶工程用于生物医学应用。
Adv Mater. 2024 Mar;36(10):e2211147. doi: 10.1002/adma.202211147. Epub 2023 Apr 4.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Catalytic Mechanisms of Nanozymes and Their Applications in Biomedicine.纳米酶的催化机制及其在生物医学中的应用。
Bioconjug Chem. 2019 May 15;30(5):1273-1296. doi: 10.1021/acs.bioconjchem.9b00171. Epub 2019 Apr 22.
10
Recent advances in metal oxide nanozyme-based optical biosensors for food safety assays.基于金属氧化物纳米酶的光学生物传感器在食品安全分析中的最新进展。
Food Chem. 2024 Jul 30;447:139019. doi: 10.1016/j.foodchem.2024.139019. Epub 2024 Mar 13.

引用本文的文献

1
Disparities in Fungal Diagnostic Capacity Across Chinese Hospitals: A Nationwide Survey Highlighting Gaps in Molecular Testing and GDP-Linked Inequalities.中国医院真菌诊断能力的差异:一项强调分子检测差距和与GDP相关不平等的全国性调查
Mycopathologia. 2025 Aug 24;190(5):77. doi: 10.1007/s11046-025-00982-2.
2
Exploring the application of herbal photosensitizers in antimicrobial photodynamic therapy against .探索草药光敏剂在抗……抗菌光动力疗法中的应用
3 Biotech. 2025 Feb;15(2):48. doi: 10.1007/s13205-024-04205-1. Epub 2025 Jan 20.
3
Advancing Microfluidic Immunity Testing Systems: New Trends for Microbial Pathogen Detection.

本文引用的文献

1
Aerobic Vaginitis Diagnosis Criteria Combining Gram Stain with Clinical Features: An Establishment and Prospective Validation Study.结合革兰氏染色与临床特征的需氧菌性阴道炎诊断标准:一项建立与前瞻性验证研究
Diagnostics (Basel). 2022 Jan 13;12(1):185. doi: 10.3390/diagnostics12010185.
2
Clinical Trial: Magnetoplasmonic ELISA for Urine-based Active Tuberculosis Detection and Anti-Tuberculosis Therapy Monitoring.临床试验:用于基于尿液的活动性结核病检测和抗结核治疗监测的磁等离子体酶联免疫吸附测定法
ACS Cent Sci. 2021 Nov 24;7(11):1898-1907. doi: 10.1021/acscentsci.1c00948. Epub 2021 Oct 26.
3
Nanozymes in Tumor Theranostics.
推进微流控免疫测试系统:微生物病原体检测的新趋势。
Molecules. 2024 Jul 15;29(14):3322. doi: 10.3390/molecules29143322.
4
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.纳米技术在防治感染性和炎症性疾病方面的前沿应用:预防与治疗。
Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z.
5
Application of the Peroxidase‒like Activity of Nanomaterials for the Detection of Pathogenic Bacteria and Viruses.纳米材料过氧化物酶样活性在致病细菌和病毒检测中的应用。
Int J Nanomedicine. 2024 Jan 16;19:441-452. doi: 10.2147/IJN.S442335. eCollection 2024.
6
Aptamer-functionalized MOFs and AI-driven strategies for early cancer diagnosis and therapeutics.适体功能化的金属有机框架及用于早期癌症诊断与治疗的人工智能驱动策略。
Biotechnol Lett. 2024 Feb;46(1):1-17. doi: 10.1007/s10529-023-03454-z. Epub 2023 Dec 28.
7
Recent Development and Application of "Nanozyme" Artificial Enzymes-A Review.“纳米酶”人工酶的研究进展与应用——综述
Biomimetics (Basel). 2023 Sep 21;8(5):446. doi: 10.3390/biomimetics8050446.
8
Recent Advances in Nanozyme-Mediated Strategies for Pathogen Detection and Control.纳米酶介导的病原体检测与控制策略的最新进展。
Int J Mol Sci. 2023 Aug 28;24(17):13342. doi: 10.3390/ijms241713342.
9
An In Situ Study on Nanozyme Performance to Optimize Nanozyme-Strip for Aβ Detection.原位研究纳米酶性能以优化用于 Aβ 检测的纳米酶条。
Sensors (Basel). 2023 Mar 24;23(7):3414. doi: 10.3390/s23073414.
肿瘤诊疗中的纳米酶
Front Oncol. 2021 Oct 19;11:666017. doi: 10.3389/fonc.2021.666017. eCollection 2021.
4
Nanozyme-Participated Biosensing of Pesticides and Cholinesterases: A Critical Review.纳米酶参与的农药和胆碱酯酶生物传感:批判性评价。
Biosensors (Basel). 2021 Oct 9;11(10):382. doi: 10.3390/bios11100382.
5
Recent Advances in the Use of Mesoporous Silica Nanoparticles for the Diagnosis of Bacterial Infections.介孔硅纳米颗粒在细菌性感染诊断中的应用研究进展
Int J Nanomedicine. 2021 Sep 24;16:6575-6591. doi: 10.2147/IJN.S273062. eCollection 2021.
6
How effective are social distancing policies? Evidence on the fight against COVID-19.社交距离政策的效果如何?抗击 COVID-19 的证据。
PLoS One. 2021 Sep 22;16(9):e0257363. doi: 10.1371/journal.pone.0257363. eCollection 2021.
7
Nanozymes in Point-of-Care Diagnosis: An Emerging Futuristic Approach for Biosensing.即时诊断中的纳米酶:一种新兴的生物传感未来方法。
Nanomicro Lett. 2021 Sep 13;13(1):193. doi: 10.1007/s40820-021-00717-0.
8
Digital Microfluidics Chips for the Execution and Real-Time Monitoring of Multiple Ribozymatic Cleavage Reactions.用于执行和实时监测多个核酶切割反应的数字微流控芯片
ACS Omega. 2021 Aug 25;6(35):22514-22524. doi: 10.1021/acsomega.1c00239. eCollection 2021 Sep 7.
9
The origins of SARS-CoV-2: A critical review.SARS-CoV-2 的起源:一项批判性回顾。
Cell. 2021 Sep 16;184(19):4848-4856. doi: 10.1016/j.cell.2021.08.017. Epub 2021 Aug 19.
10
Special Issue: Fungal Nanotechnology.特刊:真菌纳米技术
J Fungi (Basel). 2021 Jul 21;7(8):583. doi: 10.3390/jof7080583.